Diana Containerships Inc. (DCIXV) Message Board
-
It's funny how some message boards are dead, others just filled with pumpers and flamers. I have had this stock for about 14 months, it has gone up almost 17% in that time. If you think the future is generics, then look at this Indian company. It's solid, and I in particular am interested in the extent to which they will expand in emerging markets as well as the more advanced ones. India, for example, is a huge potential market.
- Reply to
CEO " We Believe The FDA Will Partner With Us To Get The Product To Patients Needing It" LINK
by tommyhill685 •May 9, 2013 10:12 AMThat's spin, but not malicious spin. The FDA does not "partner" with companies, in the sense of acting equal to equal. Sarepta is clearly the supplicant, and FDA has all the decision-making powers, but if looks like the FDA is looking benevolently on Sarepta, great!
-
I bet your English teacher in high school cringed when she saw your writing. Sheesh -- don't you even know that in high school, the aim is to get LAID, not "layed"?
-
perhaps the recent raising of money will solve those issues.
-
Since December 10,2002 -- roughly ten years -- my holdings are up 658%. Not quite Oracle, but a great stock in the long run. you will see people on this board saying other companies are good on Big Data; that IBM is going to crush it; etc. etc. I don't believe it. Big Data is going to make a bunch of companies well off. But I'd been worried earlier. It's P/E ratio was high, and the economic conditions did not seem to justify the price. I think now, with a lower P/E, good PEG ratio, and decent P/E forward ratio, that it's gone back to being a good long-term buy. Most importantly, I hope that spending on Big Data purchases will be up (Teradata estimates 6% revenue growth this year.) So -- yes, I think this might be a good entry point.
- Reply to
MINING is going down on his sister on this data, he'll have to get his rent somewhere.
by miningsuxclsncrank •May 2, 2013 3:57 AMYou're a member since May 2,2013? Sign of a pumper. . . .
- Reply to
MINING is going down on his sister on this data, he'll have to get his rent somewhere.
by miningsuxclsncrank •May 2, 2013 3:57 AMTouchy, touchy. Perhaps you should read my post carefully before spouting.
-
I thought the Seeking Alpha piece was mostly a puff piece. One with two spelling errors as well -- don't they edit? What no one knows now is whether the data mining has lead to discovery of results that are statistically significant. (As to whether data mining is a scam -- that is an absurd proposition that betrays an ignorance of what data mining is.) In the end, I agree with you that the upside is greater than the downside, but I am not wildly optimistic.
- Reply to
MINING is going down on his sister on this data, he'll have to get his rent somewhere.
by miningsuxclsncrank •May 2, 2013 3:57 AMI don't like the Holocaust denier either, but I don't make infantile comments, as you do, about his mother and sister. Grow up.
- Reply to
WHY DOES OBAMA HATE AMERICANS. FBI CANT QUESTION BOMBERS OBAMA SAYS
by chance2253 •Apr 25, 2013 9:25 PMYou're obviously what is called a "low-information voter." The FBI has already been questioning the bomber, as well as his mother. Any other misinformation you need cleared up?
-
I'm up 200%. Why sell?
-
Such boards are hard to find, especially when the morons, the pumpers, and the shorts get wind of them.
-
Look at the Prana Biotechnology (PRAN) board.
-
CLSN did NOT say that there was "statistically significant" improvement using Thermodox. That was what I wanted to hear, and I have yet to hear it.
-
Learn to spell. Strange as it is, people don't respect others who appear illiterate.
- Reply to
should have just kept my short going -this stock is a joke $7.50 to $4s..longs are clowns
by elmaestro111 •Apr 23, 2013 9:54 AMSome of us did not buy at 7.50. Calling us clowns, when we bought at a far lower price than you seem to have done, is rich.
-
up 37% since I bought it a few months ago -- if that is a crash, I like it.
- Reply to
Synergy Pharmaceuticals (SGYP) following the pricing of the underwritten public offering Biotech News Stock Review is projecting that SGYP is set to announce that is is involved in acquisition negotiations with Genentech. Adam believes that SGYP is going to have a very good next 10 days, look for big news!
by biotechnewsstockreview •Apr 13, 2013 9:07 PMIt is written by a person who seems perpetually out of breath but excited. . .
-
Well, I am still profitting from my initial investment -- why would I sell?
-
I am not a short. I like this company. It bothers me not the least that the price has dropped, since the reason is a good one. If you look at the fundamentals for this company, the long-term is looking good.
Sentiment: Strong Buy